Delivery Order SPE2DR25D1205-SPE2DR26F1ES4
Award Date 4/2/26
Potential Completion Date 4/23/26
Potential Value $26K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on April 1, 2026, with a ceiling value of $31,268.34 for Ocrevus 300 mg/10 mL vials. This delivery order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. The order carries a firm fixed price and an ultimate completion date of April 22, 2026.
- <p>The Defense Logistics Agency issued a $25,637.70 delivery order to Amerisourcebergen Drug Corp on April 9, 2026, for Ocrevus 300 mg/10 mL vials under a firm fixed-price arrangement. Ultimate completion date is April 30, 2026. Place of performance is Conshohocken, PA.</p> <p>The order is issued under the DLA Troop Support Medical indefinite delivery contract (SPE2DX), a $999,999,999 vehicle through December 2026 supporting global pharmaceutical supply for military healthcare programs.</p>
- The Defense Logistics Agency issued a $25,637.70 delivery order to Amerisourcebergen Drug Corp on April 2, 2026, for Ocrevus 300 mg/10 mL vial (10 mL) pharmaceutical supply, with ultimate completion by April 23, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026, which provides global pharmaceutical support to military healthcare programs. Place of performance is Conshohocken, PA. Pricing is...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for Ocrevus 300 mg/10 ml vial 10 ml, with a ceiling value of $76,913.10. Place of performance is Conshohocken, PA. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (SPE2DX), a global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026, which enables supply of a comprehensive range of pharmaceutical products and medical supplies...
- The Defense Logistics Agency issued a $51,275.40 delivery order to Amerisourcebergen Drug Corp on April 9, 2026, for Ocrevus 300 mg/10 mL vials, with ultimate completion on April 30, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at $999,999,999.00 through December 2026), which provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is Conshohocken, PA. The order is firm fixed price with...
- The Defense Logistics Agency issued a $29,247.58 delivery order to AmerisourceBergen Drug Corp on March 10, 2026, for OCREVUS 300 mg/10 mL vials. The order is issued under the parent DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. Ultimate completion date is March 31, 2026....
- The Defense Logistics Agency issued a $128,188.50 firm fixed-price delivery order to Amerisourcebergen Drug Corp on March 3, 2026, for Ocrevus 300 mg/10 mL vials. The order is placed against the DLA Troop Support Medical IDC, a $999,999,999 indefinite delivery contract running through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. Ultimate completion date is March 24, 2026.
- The Defense Logistics Agency issued a $76,913.10 delivery order to Amerisourcebergen Drug Corp on April 6, 2026, for Ocrevus 300 mg/10 mL vial pharmaceutical supply, with ultimate completion on April 27, 2026. The order is issued under the DLA Troop Support Medical indefinite delivery contract (SPE2DX), a $999,999,999 vehicle through December 2026 that supplies a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs. Pricing is...
- <p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 26, 2026, with a ceiling value of $76,913.10 for OCREVUS 300 mg/10 mL vials.</p> <p>The order is issued under the DLA Troop Support Medical IDC held by parent company Cencora, Inc., valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. The order carries an ultimate completion date of March 19, 2026 and is priced on a firm fixed-price basis.</p>
- <p>The Defense Logistics Agency issued a $51,493.52 delivery order to Amerisourcebergen Drug Corp on February 24, 2026, for OCREVUS 300 mg/10 mL vials.</p> <p>The order is placed against Amerisourcebergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. Place of performance is Conshohocken, PA. The ultimate completion date is March 17, 2026. Pricing is firm fixed price with no set-aside applied.</p>